Related Experiment Video
Updated: Aug 13, 2026

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018
[Critical analysis of the new ministerial order about guidelines in immunohaematology]
1Etablissement français du sang-Nord de France, site de Lille, 21, rue Camille-Guérin, BP 2018, 59012 cedex, Lille, France. lucienne.mannessier@efs.sante.fr <lucienne.mannessier@efs.sante.fr>
The evolution of the methods used in immunohematology is a constant concern for all those involved in the process. Thus, during the last few years, new technologies have been introduced which aim at improving performance. This improvement is not limited to the search for an overall increase in specificity-sensibility; it also takes into account the capability to detect "the clinical significant" as well as the limitations of human reliability, which justifies the introduction of automation and computerization. The whole of these methodological evolutions associated with that of the performance of re-agents, legitimate to modify the law about the realization of erythrocyte typing and detection of irregular antibodies. In order to ensure the immunohematologic safety of transfusions, it was also necessary to place the entire transfusion process under computer control: patient identification, sample collection, test results and release of blood.
The evolution of the methods used in immunohematology is a constant concern for all those involved in the process. Thus, during the last few years, new technologies have been introduced which aim at improving performance. This improvement is not limited to the search for an overall increase in specificity-sensibility; it also takes into account the capability to detect "the clinical significant" as well as the limitations of human reliability, which justifies the introduction of automation and computerization. The whole of these methodological evolutions associated with that of the performance of re-agents, legitimate to modify the law about the realization of erythrocyte typing and detection of irregular antibodies. In order to ensure the immunohematologic safety of transfusions, it was also necessary to place the entire transfusion process under computer control: patient identification, sample collection, test results and release of blood.
More Related Videos
Related Concept Videos
Regulation of Hematopoietic Stem Cells
Blood Transfusion
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...

